The performance of two AI chatbots in the ophthalmology board examination.
Sarepta’s gene therapy to be manufactured at Catalent plant with ‘operational challenges’ this spring
Catalent, the contract manufacturer in the process of overhauling its operations, is manufacturing Sarepta Therapeutics’ newly approved gene therapy for Duchenne muscular dystrophy at one